The future of smoking cessation therapy in the United States

  1. JOHN R. HUGHES*

Article first published online: 24 JAN 2006

DOI: 10.1046/j.1360-0443.1996.911217974.x

Issue

Addiction

Addiction

Volume 91, Issue 12, pages 1797–1802, December 1996

Additional Information

How to Cite

HUGHES, J. R. (1996), The future of smoking cessation therapy in the United States. Addiction, 91: 1797–1802. doi: 10.1046/j.1360-0443.1996.911217974.x

Author Information

  1. Human Behavioral Pharmacology Laboratory, University of Vermont, USA

* John R. Hughes, MD, University of Vermont, Department of Psychiatry, 38 Fletcher Place, Burlington, VT 05401-1419, USA. Tel: 802-660-3060; Fax: 802-660-3064; e-mail: john.hughes@uvm.edu

Publication History

  1. Issue published online: 24 JAN 2006
  2. Article first published online: 24 JAN 2006
  3. Submitted 6th December 1995; initial review completed 27th March 1996; final version accepted 23rd May 1996.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (440K)

Abstract

Six trends that are likely to influence the future content, format, delivery and reach of smoking cessation therapy in the United States are discussed: (1) changing characteristics of smokers (e.g. more likely to be poor, have psychiatric co-morbidity and be more nicotine dependent), (2) health care reform demands for cost-effectiveness, (3) development of guidelines/algorithms that recommend stepped-care approaches, (4) continued emphasis on smoking as a form of drug dependence requiring intensive pharmacological and behavior therapy for some smokers, (5) interest in harm-reduction strategies for smokers unable or unwilling to qua (and 6) smoking cessation therapies become reimbursable on par with other drug dependencies.

Get PDF (440K)